The U.S. government’s Countermeasures Injury Compensation Program (CICP) is backlogged by 10 years, according to a testimony given before the Select Subcommittee on the Coronavirus Pandemic.
“In the year 2023, we processed 90 claims per month over that year,” the individual said.
As of January 1, 2024, there are 10,640 COVID-19 vaccine injury claims to be reviewed.
Rep. Rich McCormick (R-GA) said, “Just to do the math, that means that each employee is handling about 2.7 cases per month … it would take us about 10 years to process the remaining claims.”
Out of the 2,214 claims that have been reviewed as of January 1, 2024, 40 were found to be eligible for compensation. Of those, only 11 received the compensation.
American Faith reported that a study published in the digital journal Cureus acknowledged that the risks presented by the COVID-19 mRNA vaccines “outweigh the rewards.”
It suggested that “for every life saved, there were nearly 14 times more deaths caused by the modified mRNA injections.”
According to the study’s authors, the claim that the mRNA vaccines were “safe and effective” was “dubious at best,” explaining that it took an estimated 52,000 vaccinations to prevent one death.
“Federal agency approval of the COVID-19 mRNA vaccines on a blanket-coverage population-wide basis had no support from an honest assessment of all relevant registrational data and commensurate consideration of risks versus benefits,” the study added. “Given the extensive, well-documented SAEs [serious adverse events] and unacceptably high harm-to-reward ratio, we urge governments to endorse a global moratorium on the modified mRNA products until all relevant questions pertaining to causality, residual DNA, and aberrant protein production are answered.”
